DD-S052P

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDD-S052P
Drug Alias Nameantibiotic (HLB Science)DD-S052P
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionSepsisGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHlb Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHLB ScienceHlb Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionSepsisGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A